Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis

Background and Aim: In gastroesophageal reflux disease (GERD), the additive effect of mosapride to a proton pump inhibitor (PPI) is still controversial. This meta-analysis integrated randomized controlled trials (RCTs) in which mosapride combined with a PPI was compared with a PPI alone in GERD trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishizawa, Toshihiro, Mori, Kiyoto, Yoshida, Shuntaro, Ebinuma, Hirotoshi, Toyoshima, Osamu, Suzuki, Hidekazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565487/
https://www.ncbi.nlm.nih.gov/pubmed/32825721
http://dx.doi.org/10.3390/jcm9092705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565487/
https://www.ncbi.nlm.nih.gov/pubmed/32825721
http://dx.doi.org/10.3390/jcm9092705

Ejemplares similares